Product Details
Risperdal Consta
Risperidone37.5 mg
Powder for Injectable Prolonged-Release Suspension
Vial Pack
DIN/PIN/NPN
02255723
Manufacturer
Janssen Inc.
Formulary Listing Date
2008-08-28
Unit Price
312.5100
Amount MOH Pays
312.5100
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Risperidone 37.5 mg Powder for Injectable Prolonged-Release Suspension in Vial: For the treatment of schizophrenia or schizoaffective disorders in patients who have: A history of non-adherence; AND one of the following: (a) Inadequate control or significant side-effects from two or more formulary oral antipsychotic medications, including at least one atypical agent; OR (b) Inadequate control or significant side-effects from one or more conventional depot antipsychotic agents.
ATC Code
N05AX08